{"name":"Lifespan","slug":"lifespan","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Sublocade","genericName":"Sublocade","slug":"sublocade","indication":"Other","status":"marketed"},{"name":"injectable naltrexone","genericName":"injectable naltrexone","slug":"injectable-naltrexone","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Sublocade","genericName":"Sublocade","slug":"sublocade","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"injectable naltrexone","genericName":"injectable naltrexone","slug":"injectable-naltrexone","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPaHAyeVpIRGtReU54Nm11RV85YW1YeVdWVzVBaHdUN01zVVoyRkF4VThsN2M3RGEwQjFkNFNzTTdUM3VzNWU4UEZWTHg4NEdFUlZXczZmTDJzbHVvOUg2RG1XWkZ1NGlwZ3BDd0pueThGb1hsYXpPalBvT3loU2xVM2xDMVFxenVkcVJBaG41eWgzanBCUlAzVS1UVDdzZWd0YnM0TVVxNk0yQUpPd3c?oc=5","date":"2026-04-06","type":"pipeline","source":"Fierce Pharma","summary":"VML Health urges marketers to shift from lifespan to ‘joyspan’ as patient goals evolve - Fierce Pharma","headline":"VML Health urges marketers to shift from lifespan to ‘joyspan’ as patient goals evolve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPelFjNGx1XzlmcGNUb3ZuZ29MellFaTZwQ0x4dDM4WGtGUlFjOEJfbWl0RWVYWXUwbWVPRlFQU1ZPNGt3LVl5aC1RVXA4V3dDMWZQckZNdmthZFpPRWd2ckZmdTM4ZTVOcHdvNTN2UVZ0bjIzeFBqbmZlYW5SaHVhV2VQYUx0akR3R3c?oc=5","date":"2026-03-20","type":"pipeline","source":"pharmaphorum","summary":"Longevity is not a consumer trend, but a pipeline strategy problem - pharmaphorum","headline":"Longevity is not a consumer trend, but a pipeline strategy problem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE5sM1YzS3RXZWxWQmJiMHQ5OGNTRklxa1Q4OTJLbDdERzdVWUY2MkVzbHYxR0JXRURTT0pCbmpELWVyNTNjYk56TWNsSENiamRWUEVMa1VDV2tHQUJXM1dBRFR5SDZyYzVKUDRtSUxXZHdOQkU?oc=5","date":"2026-03-17","type":"pipeline","source":"The Motley Fool","summary":"Biotech Stocks & Longevity Investing: Trends to Track - The Motley Fool","headline":"Biotech Stocks & Longevity Investing: Trends to Track","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE0zMjVrdVpqQU40Z1p6Tm5vMUctWXNuMTU4V2loV2IzMXVzZWNQRDY1UlMzVlp4VGJtaDVHdVUzRWxpeXZWVTA0UWRycHlpa1ZHS0dRTUNBTEpoamM5RGctLU05WEtZY0VaU0QtNWRXX3pweXUyQnc?oc=5","date":"2026-03-16","type":"pipeline","source":"labiotech.eu","summary":"13 anti-aging biotech companies to watch in 2026 - labiotech.eu","headline":"13 anti-aging biotech companies to watch in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNY0stRkIza2UwMDEtY2pQN1hMQWdmdTUtN1JkTUdGWTM0QnZJY1pPaVVFLURsUzRmS0NoaDZ0dF9UTmswR1A3eTI3U3lUbl9JRzVzcUxVVDJvSEZjaHNyZ2NWX0NQMHJDMEhxU3VRODFhcjBtajdDcDF1WXp3Q2xwc0NBWnFfbXVjd3NWdHhfNVVRWkhmRTlZNjFDdzNQdE1TMVJV?oc=5","date":"2026-03-02","type":"pipeline","source":"Clarivate","summary":"Pharmas and biotechs are investing in new treatments for diseases of aging - Clarivate","headline":"Pharmas and biotechs are investing in new treatments for diseases of aging","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxORFFFamFDd0M5Q0N0WG9LT3NHajh1S3VKQW1oS3RObGh6TUdzaTdybEhYdTM3SFJCM25WUTVKdUZFdnhqV0g3VExWNXE0X1QzZVVLaXd2UmRXZWlHR2VTV09iTGlVLUotZmRnWWFOX05BUmxXM0ZJNGRkRmlTYUZ1NEdPUQ?oc=5","date":"2026-01-19","type":"pipeline","source":"pharmaphorum","summary":"The frontier of 3D biofabrication in the race for healthy longevity - pharmaphorum","headline":"The frontier of 3D biofabrication in the race for healthy longevity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5VT2IwVy1QVVgtZDZ4X2c1TW5NUXJtRDNtNlJkdkpQM1I4M1dkd1NUaTZfdnZxcEJ4cl85d3VfQ1k0OTE5M2JhQ3VFQWJSSlRjNWhTZXpsYVVXRERDSnBkaHgtSFpjMFFTa09USkVJTl9FWk5ZYUhSNHFB?oc=5","date":"2026-01-06","type":"pipeline","source":"lifespan.io","summary":"Longevity Biotech in 2025: The Expert Roundup - lifespan.io","headline":"Longevity Biotech in 2025: The Expert Roundup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5Bd3BsYUo5ZTFKcWMwRTFSSVByQkVpSW5TY0RGYm5fdWd0Q1JqcmVqM0tXNms3Y2JVRUYzdUxhcm9jZkJCOGFrQ00zTEROVDEyT1JfYWN2SGVXSnRfdUtibThiWk9OTXBfNFE?oc=5","date":"2025-11-12","type":"pipeline","source":"statnews.com","summary":"AbbVie cuts ties with Google-backed longevity company, lays off scientists - statnews.com","headline":"AbbVie cuts ties with Google-backed longevity company, lays off scientists","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOWjVSVmxOb0Z3VDJXUGRROWxhZ2lmbEhXZGQwR0ZVNk5lTnFlY0dpajVaRFlHbWVpcmFodGZsX24teThVWDdXWGxfOHUwM0NRaUdrVGpHVkJ5S0xrV0l2QVBzSTFDaWx4NEk1YVBoaWFJQ0tkWlVEUjFRVWJHZ3hMWUxSWlNwcUVGMV83VEFPekNwcG1KZXVMOFh6OVB6dUotSzFnQTdheG9iTFRhZm15QTBnZmtob0RIVm1RTHV4SzdkaHRBclEzZUlacUxUdFBTbUpPQg?oc=5","date":"2025-10-23","type":"pipeline","source":"Forbes","summary":"Pelage Pharma’s Longevity Bet on Stem-Cell Hair Restoration - Forbes","headline":"Pelage Pharma’s Longevity Bet on Stem-Cell Hair Restoration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPYzltLVY4elNURGhMSmpRYzFybzNEcTRUNktHS3ZrZWhneGtiell1cjlfalJMZEk2QVRweXZ5enFYUGxuQTdFWkNtelZicFVWaERUeHJ2cTdrWUczZ1Q4bF9jMFVOUXBySi01MW9xcUJDVWJCNE15ME91N0Zyc0ktY2xURkJ4dHdNQ2dkVXlwUktiNk5WS2w4SUVlcGZWeU9DWXNCYUdIQXpsYmRfb2VERE11U1dFaGVwY2pzNzY4QTg1cHVSSFJDMG8zcFQ?oc=5","date":"2025-10-01","type":"deal","source":"Contract Pharma","summary":"Klotho Neurosciences to Acquire Longevity Therapeutic Assets from Turn Biotechnologies - Contract Pharma","headline":"Klotho Neurosciences to Acquire Longevity Therapeutic Assets from Turn Biotechnologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOc1dfMWItRjlfNWdrWnFCQndFRF9zakhHR3FjLTJzS0J3M2NTd2ZaYlNIdDQxSnBkUEhOdjhzeDJfd2ZBNlRnQ2hVM0pxMVF5Yk84em15bnFBYk1uX1ZhR3EwSVBjRUhVRzdxdDZ5bC01M2U2YUw3ZjE4ZHRaNWxNMg?oc=5","date":"2025-09-15","type":"pipeline","source":"Longevity.Technology","summary":"GLP-1s claim the longevity stage at ARDD - Longevity.Technology","headline":"GLP-1s claim the longevity stage at ARDD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOa1JCdDBRNGFSX3VSSHR4aTQwN3Rmeks0VWlpRXdpTlo5Z2xmSjdDYTlnYVhjYk1KbHBGWlZDcjgzUDdNcDV3a2tudVNOOHUzOVhpcElaV3BFR3hXWUd4Ykw1MmhtUXE4dWRRQ0U2QmZYMGVFSExBUThYQ1pwbFNpMEZCU2l2bFZpWmRGVGJpdVpINDMwMXBOWll6ZzNuR1gtRUE?oc=5","date":"2025-06-28","type":"pipeline","source":"7wire Ventures","summary":"Turning Lifespan into Healthspan: The Future of Longevity - 7wire Ventures","headline":"Turning Lifespan into Healthspan: The Future of Longevity - 7wire Ventures","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}